Invitae Corporation (NVTA) EPS Estimated At $-0.47

October 16, 2018 - By Marie Mckinney

Invitae Corporation (NYSE:NVTA) Logo

Analysts expect Invitae Corporation (NYSE:NVTA) to report $-0.47 EPS on November, 5.They anticipate $0.10 EPS change or 17.54 % from last quarter’s $-0.57 EPS. After having $-0.47 EPS previously, Invitae Corporation’s analysts see 0.00 % EPS growth. The stock increased 2.90% or $0.4 during the last trading session, reaching $14.2. About 1.16 million shares traded. Invitae Corporation (NYSE:NVTA) has risen 45.54% since October 17, 2017 and is uptrending. It has outperformed by 29.92% the S&P500.

Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally. The company has market cap of $980.48 million. The firm processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. It currently has negative earnings. It provides a diagnostic service comprising hundreds of genes for various genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas.

Another recent and important Invitae Corporation (NYSE:NVTA) news was published by which published an article titled: “Sonos Is Inconsistent – Cramer’s Lightning Round (9/17/18)” on September 18, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News